Immunodeficiency.
Justiz Vaillant AA, Qurie A.
2023 Jun 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Basophilic leukemia.
Jennings CV, Dannaher CL, Yam LT.
South Med J. 1980 Jul;73(7):934-6. doi: 10.1097/00007611-198007000-00031.
Hyper-CVAD-Based Stem Cell Microtransplant as Post-Remission Therapy in Acute Lymphoblastic Leukemia.
Cai B, Wang Y, Lei Y, Shi Y, Sun Q, Qiao J, Hu K, Lei Y, Li B, Liu T, Liu Z, Yao B, Zhao X, Li X, Zhao W, Feng X, Xie A, Ning X, Feng M, Zhao W, Guo J, Ai H, Yu C, Guo M.
Stem Cells Transl Med. 2022 Nov 18;11(11):1113-1122. doi: 10.1093/stcltm/szac066.
Malignant A-to-I RNA editing by ADAR1 drives T cell acute lymphoblastic leukemia relapse via attenuating dsRNA sensing.
Rivera M, Zhang H, Pham J, Isquith J, Zhou QJ, Balaian L, Sasik R, Enlund S, Mark A, Ma W, Holm F, Fisch KM, Kuo DJ, Jamieson C, Jiang Q.
Cell Rep. 2024 Feb 27;43(2):113704. doi: 10.1016/j.celrep.2024.113704. Epub 2024 Jan 23.
Role of natural killer cells for immunotherapy in chronic myeloid leukemia (Review).
Lee HR, Baek KH.
Oncol Rep. 2019 May;41(5):2625-2635. doi: 10.3892/or.2019.7059. Epub 2019 Mar 13.
Adverse prognostic impact of CDKN2B hyper-methylation in acute promyelocytic leukemia.
Chim CS, Kwong YL.
Leuk Lymphoma. 2006 May;47(5):815-25. doi: 10.1080/10428190500513827.
Signal transducer and activator of transcription 3: a year in review.
Forbes LR, Milner J, Haddad E.
Curr Opin Hematol. 2016 Jan;23(1):23-7. doi: 10.1097/MOH.0000000000000206.
Feasibility and outcome of the hyper-CVAD regimen in patients with adult acute lymphoblastic leukemia.
Portugal RD, Loureiro MM, Garnica M, Pulcheri W, Nucci M.
Clin Lymphoma Myeloma Leuk. 2015 Jan;15(1):52-7. doi: 10.1016/j.clml.2014.03.004. Epub 2014 Jun 12.
Hyper-CVAD: a regimen for all seasons.
Seftel MD.
Lancet Haematol. 2020 Jul;7(7):e501-e502. doi: 10.1016/S2352-3026(20)30179-4.
New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia.
Moorman AV.
Haematologica. 2016 Apr;101(4):407-16. doi: 10.3324/haematol.2015.141101.
